Literature DB >> 19278656

Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.

Patrick Walsh1, Karen Simonetti, Simon Sharpe.   

Abstract

Peptides comprising residues 106-126 of the human prion protein (PrP) exhibit many features of the full-length protein. PrP(106-126) induces apoptosis in neurons, forms fibrillar aggregates, and can mediate the conversion of native cellular PrP (PrP(C)) to the scrapie form (PrP(Sc)). Despite a wide range of biochemical and biophysical studies on this peptide, including investigation of its propensity for aggregation, interactions with cell membranes, and PrP-like toxicity, the structure of amyloid fibrils formed by PrP(106-126) remains poorly defined. In this study we use solid-state nuclear magnetic resonance to define the secondary and quaternary structure of PrP(106-126) fibrils. Our results reveal that PrP(106-126) forms in-register parallel beta sheets, stacked in an antiparallel fashion within the mature fibril. The close intermolecular contacts observed in the fibril core provide a rational for the sequence-dependent behavior of PrP(106-126), and provide a basis for further investigation of its biological properties.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19278656     DOI: 10.1016/j.str.2008.12.018

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  34 in total

1.  The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance.

Authors:  Robert Tycko; Regina Savtchenko; Valeriy G Ostapchenko; Natallia Makarava; Ilia V Baskakov
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  Domain swapping and amyloid fibril conformation.

Authors:  Patrick C A van der Wel
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

3.  Structural polymorphism in amyloids: new insights from studies with Y145Stop prion protein fibrils.

Authors:  Eric M Jones; Bo Wu; Krystyna Surewicz; Philippe S Nadaud; Jonathan J Helmus; Shugui Chen; Christopher P Jaroniec; Witold K Surewicz
Journal:  J Biol Chem       Date:  2011-10-15       Impact factor: 5.157

4.  Amyloid-like fibrils from a domain-swapping protein feature a parallel, in-register conformation without native-like interactions.

Authors:  Jun Li; Cody L Hoop; Ravindra Kodali; V N Sivanandam; Patrick C A van der Wel
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

5.  Structural studies of truncated forms of the prion protein PrP.

Authors:  William Wan; Holger Wille; Jan Stöhr; Amy Kendall; Wen Bian; Michele McDonald; Sarah Tiggelaar; Joel C Watts; Stanley B Prusiner; Gerald Stubbs
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

Review 6.  Understanding amyloid fibril formation using protein fragments: structural investigations via vibrational spectroscopy and solid-state NMR.

Authors:  Benjamin Martial; Thierry Lefèvre; Michèle Auger
Journal:  Biophys Rev       Date:  2018-05-31

Review 7.  The supramolecular chemistry of β-sheets.

Authors:  Pin-Nan Cheng; Johnny D Pham; James S Nowick
Journal:  J Am Chem Soc       Date:  2013-04-02       Impact factor: 15.419

8.  The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by prion protein(106-126) is dependent on bilayer composition.

Authors:  Patrick Walsh; Gillian Vanderlee; Jason Yau; Jody Campeau; Valerie L Sim; Christopher M Yip; Simon Sharpe
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

9.  Stacked sets of parallel, in-register beta-strands of beta2-microglobulin in amyloid fibrils revealed by site-directed spin labeling and chemical labeling.

Authors:  Carol L Ladner; Min Chen; David P Smith; Geoffrey W Platt; Sheena E Radford; Ralf Langen
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

10.  Solution structure and dynamics of the I214V mutant of the rabbit prion protein.

Authors:  Yi Wen; Jun Li; Minqian Xiong; Yu Peng; Wenming Yao; Jing Hong; Donghai Lin
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.